vs

Side-by-side financial comparison of PRO DEX INC (PDEX) and Red Cat Holdings, Inc. (RCAT). Click either name above to swap in a different company.

PRO DEX INC is the larger business by last-quarter revenue ($18.7M vs $9.6M, roughly 1.9× Red Cat Holdings, Inc.). PRO DEX INC runs the higher net margin — 11.7% vs -166.0%, a 177.8% gap on every dollar of revenue. On growth, Red Cat Holdings, Inc. posted the faster year-over-year revenue change (988.2% vs 11.1%). PRO DEX INC produced more free cash flow last quarter ($3.5M vs $-24.5M).

Pro Dex Inc is a precision manufacturing enterprise that produces custom machined components, subassemblies and finished products primarily for medical device original equipment manufacturers, as well as clients in the aerospace and industrial sectors, with its core operating market covering North America.

Mega Cat Studios is an American video game development and publishing company located in Pittsburgh, Pennsylvania. It was founded in 2015 by James Deighan, Nick Mann, and Zack Manko.

PDEX vs RCAT — Head-to-Head

Bigger by revenue
PDEX
PDEX
1.9× larger
PDEX
$18.7M
$9.6M
RCAT
Growing faster (revenue YoY)
RCAT
RCAT
+977.1% gap
RCAT
988.2%
11.1%
PDEX
Higher net margin
PDEX
PDEX
177.8% more per $
PDEX
11.7%
-166.0%
RCAT
More free cash flow
PDEX
PDEX
$28.0M more FCF
PDEX
$3.5M
$-24.5M
RCAT

Income Statement — Q2 FY2026 vs Q3 FY2025

Metric
PDEX
PDEX
RCAT
RCAT
Revenue
$18.7M
$9.6M
Net Profit
$2.2M
$-16.0M
Gross Margin
30.8%
6.6%
Operating Margin
17.5%
-181.7%
Net Margin
11.7%
-166.0%
Revenue YoY
11.1%
988.2%
Net Profit YoY
7.2%
-29.0%
EPS (diluted)
$0.66
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PDEX
PDEX
RCAT
RCAT
Q4 25
$18.7M
Q3 25
$18.5M
$9.6M
Q2 25
$17.5M
Q1 25
$17.4M
$1.6M
Q4 24
$16.8M
$0
Q3 24
$14.9M
Q2 24
$15.0M
Q1 24
$14.3M
$5.8M
Net Profit
PDEX
PDEX
RCAT
RCAT
Q4 25
$2.2M
Q3 25
$4.7M
$-16.0M
Q2 25
$1.2M
Q1 25
$3.3M
$-23.1M
Q4 24
$2.0M
$-13.3M
Q3 24
$2.5M
Q2 24
$1.6M
Q1 24
$655.0K
$-5.5M
Gross Margin
PDEX
PDEX
RCAT
RCAT
Q4 25
30.8%
Q3 25
29.0%
6.6%
Q2 25
19.9%
Q1 25
33.3%
-52.2%
Q4 24
30.2%
Q3 24
34.6%
Q2 24
27.2%
Q1 24
28.0%
18.8%
Operating Margin
PDEX
PDEX
RCAT
RCAT
Q4 25
17.5%
Q3 25
16.8%
-181.7%
Q2 25
7.7%
Q1 25
20.9%
-765.7%
Q4 24
16.0%
Q3 24
20.2%
Q2 24
15.6%
Q1 24
15.5%
-76.0%
Net Margin
PDEX
PDEX
RCAT
RCAT
Q4 25
11.7%
Q3 25
25.3%
-166.0%
Q2 25
6.8%
Q1 25
18.8%
-1418.9%
Q4 24
12.1%
Q3 24
16.6%
Q2 24
10.6%
Q1 24
4.6%
-93.9%
EPS (diluted)
PDEX
PDEX
RCAT
RCAT
Q4 25
$0.66
Q3 25
$1.40
$-0.16
Q2 25
$0.33
Q1 25
$0.98
$-0.27
Q4 24
$0.61
Q3 24
$0.75
Q2 24
$0.44
Q1 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PDEX
PDEX
RCAT
RCAT
Cash + ST InvestmentsLiquidity on hand
$6.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.6M
$253.3M
Total Assets
$62.3M
$286.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PDEX
PDEX
RCAT
RCAT
Q4 25
$6.1M
Q3 25
$10.1M
Q2 25
$6.8M
Q1 25
$5.5M
Q4 24
$4.7M
Q3 24
$7.8M
Q2 24
$6.8M
Q1 24
$7.8M
Total Debt
PDEX
PDEX
RCAT
RCAT
Q4 25
Q3 25
Q2 25
$15.4M
Q1 25
Q4 24
Q3 24
Q2 24
$12.0M
Q1 24
Stockholders' Equity
PDEX
PDEX
RCAT
RCAT
Q4 25
$41.6M
Q3 25
$41.5M
$253.3M
Q2 25
$36.6M
Q1 25
$35.3M
$28.9M
Q4 24
$31.8M
$27.0M
Q3 24
$30.9M
Q2 24
$30.9M
Q1 24
$30.9M
$49.6M
Total Assets
PDEX
PDEX
RCAT
RCAT
Q4 25
$62.3M
Q3 25
$64.3M
$286.0M
Q2 25
$61.2M
Q1 25
$64.3M
$59.7M
Q4 24
$60.4M
$51.1M
Q3 24
$54.3M
Q2 24
$52.5M
Q1 24
$50.5M
$55.3M
Debt / Equity
PDEX
PDEX
RCAT
RCAT
Q4 25
Q3 25
Q2 25
0.42×
Q1 25
Q4 24
Q3 24
Q2 24
0.39×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PDEX
PDEX
RCAT
RCAT
Operating Cash FlowLast quarter
$3.6M
$-23.9M
Free Cash FlowOCF − Capex
$3.5M
$-24.5M
FCF MarginFCF / Revenue
18.8%
-254.2%
Capex IntensityCapex / Revenue
0.4%
6.9%
Cash ConversionOCF / Net Profit
1.63×
TTM Free Cash FlowTrailing 4 quarters
$-55.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PDEX
PDEX
RCAT
RCAT
Q4 25
$3.6M
Q3 25
$2.3M
$-23.9M
Q2 25
$-173.0K
Q1 25
$754.0K
$-15.9M
Q4 24
$-4.2M
$-10.1M
Q3 24
$1.9M
Q2 24
$1.0M
Q1 24
$4.1M
$-4.1M
Free Cash Flow
PDEX
PDEX
RCAT
RCAT
Q4 25
$3.5M
Q3 25
$2.2M
$-24.5M
Q2 25
Q1 25
$574.0K
$-16.2M
Q4 24
$-4.7M
$-10.2M
Q3 24
$1.5M
Q2 24
Q1 24
$4.0M
$-4.2M
FCF Margin
PDEX
PDEX
RCAT
RCAT
Q4 25
18.8%
Q3 25
11.9%
-254.2%
Q2 25
Q1 25
3.3%
-992.9%
Q4 24
-27.9%
Q3 24
9.8%
Q2 24
Q1 24
27.7%
-71.1%
Capex Intensity
PDEX
PDEX
RCAT
RCAT
Q4 25
0.4%
Q3 25
0.5%
6.9%
Q2 25
Q1 25
1.0%
16.8%
Q4 24
3.2%
Q3 24
2.9%
Q2 24
Q1 24
0.8%
0.8%
Cash Conversion
PDEX
PDEX
RCAT
RCAT
Q4 25
1.63×
Q3 25
0.49×
Q2 25
-0.14×
Q1 25
0.23×
Q4 24
-2.03×
Q3 24
0.77×
Q2 24
0.66×
Q1 24
6.22×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PDEX
PDEX

Segment breakdown not available.

RCAT
RCAT

Products$8.5M88%
Services$1.2M12%

Related Comparisons